- Home
- Antimicrobial Susceptibility Testing Market

Global Antimicrobial Susceptibility Testing Market - Industry Trends and Forecast to 2029
- Published Date: September, 2022 | Report ID: CLS-186 | No of pages: 392 | Format:
Global antimicrobial susceptibility testing market is projected to register a substantial CAGR of 5.9% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2029 and the forecast period is 2022 to 2029
Market Segmentation:
Global Antimicrobial Susceptibility Testing Market, By Product Type (Instruments, Consumables & Accessories & Services & Software), Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods & Others), Type (Antibacterial Testing, Antifungal Testing & Rapid-AST), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology & Others), End User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres and Academic Institutes & Others), Distribution Channel (Direct Sales, Retail Sales & Third Party Distributor), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Rest of South America, South Africa and Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the global antimicrobial susceptibility testing market are:
Growing epidemic and pandemic events
Growing technological advancements
Growing multi-drug resistant organisms
Market Players:
The key market players for global antimicrobial susceptibility testing market are listed below:
Mast Group Ltd.
ThermoFisher Scientifc, Inc.
HiMedia Laboratories
Merck KGaA
BD
Bio-Rad Laboratories, Inc.
Rosco Diagnostica A/S
Alifax S.R.L
Synbiosis
NuMedii, Inc.
Liofilchem S.r.l.
Genefluidics, Inc.
Accelerate Diagnostics, Inc.
Zhuhai DL Biotech Co., Ltd
BacterioScan, Inc.
TABLE OF CONTENT
Segmentation
Short Description
Global Antimicrobial Susceptibility Testing Market, By Product Type (Instruments, Consumables & Accessories, and Services & Software), Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods & Others), Type (Antibacterial Testing, Antifungal Testing & Rapid-AST), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology & Others), End User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres and Academic Institutes & Others), Distribution Channel (Direct Sales, Retail Sales & Third Party Distributor), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Rest of South America, South Africa, and Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Definition:
Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection. Susceptibility testing is performed on microorganisms such as bacteria, fungi causing the infection after they have been recovered in a culture of the specimen. Testing is used to determine the potential effectiveness of antibiotics on microorganisms and determine if the microorganisms have developed resistance to certain antibiotics. The results of this test can help healthcare professionals to get access to better clinical diagnosis and select the drug that is most likely to be effective in treating that particular infection.
Market Segmentation:
Global antimicrobial susceptibility testing market is categorized into six notable segments which are based on product type, methods, type, application, end user and distribution channel.
On the basis of product type, the antimicrobial susceptibility testing market is segmented into instruments, consumables & accessories and services & software
On the basis of methods, the antimicrobial susceptibility testing market is segmented into mass spectrometry method, dilution, disk diffusion, e-test, genotypic methods, and rapid-AST
On the basis of type, the antimicrobial susceptibility testing market is segmented into antibacterial testing, antifungal testing and others
On the basis of application, the antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, epidemiology and others
On the basis of end user, the antimicrobial susceptibility testing market is segmented into hospitals, pharmaceuticals and biotechnology companies, diagnostic laboratories, contract research organizations, research centres & academic institutes and others
On the basis of distribution channel, the antimicrobial susceptibility testing market is segmented into direct sales, retail sales and third party distributor
Market Players
The key market players for global antimicrobial susceptibility testing market are listed below:
Mast Group Ltd.
ThermoFisher Scientifc, Inc.
HiMedia Laboratories
Merck KGaA
BD
Bio-Rad Laboratories, Inc.
Rosco Diagnostica A/S
Alifax S.R.L
Synbiosis
NuMedii, Inc.
Liofilchem S.r.l.
Genefluidics, Inc.
Accelerate Diagnostics, Inc.
Zhuhai DL Biotech Co., Ltd
BacterioScan, Inc.
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.